December 9, 2025

Centessa Pharmaceuticals (CNTA) Investor Outlook: 25.68% Potential Upside Ignites Interest

Centessa Pharmaceuticals plc (NASDAQ: CNTA), a key player in the biotechnology sector, is capturing the attention of investors with its impressive growth potential. As a clinical-stage pharmaceutical company based in..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: Exploring the 9.55% Potential Upside

Alignment Healthcare, Inc. (NASDAQ: ALHC) stands out in the healthcare sector, particularly within the healthcare plans industry, as it leverages a consumer-centric platform tailored to seniors in the United States...

ImmunityBio, Inc. (IBRX) Stock Analysis: Unveiling a 351% Potential Upside for Bold Investors

ImmunityBio, Inc. (NASDAQ: IBRX) is capturing investor attention with its staggering 351.33% potential upside, making it a compelling consideration for those willing to explore high-risk, high-reward opportunities in the biotechnology..

Ligand Pharmaceuticals Inc. (LGND) Stock Analysis: Exploring a 28% Potential Upside

Investors with a keen interest in the biotechnology sector should take note of Ligand Pharmaceuticals Incorporated (NASDAQ: LGND), a dynamic player in the healthcare industry. With its strong market position..

Amicus Therapeutics, Inc. (FOLD): Analyst Consensus Highlights 61% Potential Upside

With a market capitalization of $3.04 billion, Amicus Therapeutics, Inc. (NASDAQ: FOLD) stands as a notable entity within the biotechnology sector, dedicated to developing innovative treatments for rare diseases. Headquartered..

Bausch Health Companies Inc. (BHC) Stock Analysis: Can the Forward P/E of 1.63 Signal a Hidden Value?

Bausch Health Companies Inc. (NYSE: BHC) presents a compelling case for investors seeking value within the healthcare sector. Trading at $6.82, the stock has seen a modest decrease of 0.02%..

Kiniksa Pharmaceuticals, Ltd. (KNSA) Stock Analysis: A Promising 29.96% Potential Upside for Investors

Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) presents an intriguing opportunity for investors looking to capitalize on the burgeoning healthcare sector. With a market capitalization of $3.15 billion, Kiniksa is a notable..

Ascentage Pharma Group (AAPG) Stock Analysis: Exploring a 43.72% Potential Upside in the Biotech Sector

Ascentage Pharma Group International (AAPG) is capturing the attention of investors with its promising potential upside in the highly competitive biotechnology sector. Headquartered in Suzhou, China, Ascentage Pharma operates in..

GeneDx Holdings Corp. (WGS) Investor Outlook: Navigating the Genomics Frontier with Promising Revenue Growth

GeneDx Holdings Corp. (NASDAQ: WGS), a leader in the healthcare sector’s diagnostics and research industry, is making significant strides with its cutting-edge genetic testing services. Headquartered in Stamford, Connecticut, the..

Acadia Healthcare Company, Inc. (ACHC) Stock Analysis: Unveiling a 54% Potential Upside in Healthcare Sector

Acadia Healthcare Company, Inc. (ACHC) stands as a significant player in the healthcare sector, particularly within the medical care facilities industry. With a market capitalization of $1.29 billion, Acadia operates..

Warby Parker Inc. (WRBY) Stock Analysis: Eyeing a 5.62% Potential Upside Amid Healthy Revenue Growth

Warby Parker Inc. (NYSE: WRBY), a prominent player in the healthcare sector under the medical instruments and supplies industry, is drawing significant attention from investors. With its current market capitalization..

Ardent Health, Inc. (ARDT) Stock Analysis: Exploring a Potential 62.68% Upside in the Healthcare Sector

Ardent Health, Inc. (NASDAQ: ARDT), a prominent player in the healthcare sector, is capturing investor attention with its potential upside of 62.68%, as suggested by analyst ratings. Headquartered in Brentwood,..

Twist Bioscience Corporation (TWST) Stock Analysis: A Promising 10.57% Potential Upside in the Healthcare Sector

Twist Bioscience Corporation (NASDAQ: TWST), a prominent player in the healthcare sector, has been capturing the attention of investors with its innovative approach to synthetic DNA production. As a company..

NovoCure Limited (NVCR) Stock Analysis: Exploring a Potential 106.7% Upside in the Healthcare Sector

NovoCure Limited (NASDAQ: NVCR), a notable player in the medical devices industry, has been making waves with its innovative approach to cancer treatment through tumor treating fields (TTFields) technology. With..

QuidelOrtho Corporation (QDEL) Stock Analysis: Navigating the 38.68% Potential Upside

As investors look to navigate the turbulent waters of the healthcare sector, QuidelOrtho Corporation (NASDAQ: QDEL) presents itself as a noteworthy player. With a market capitalization of $1.85 billion, QuidelOrtho..

MoonLake Immunotherapeutics (MLTX): A Biotech Stock with Potential Amidst Market Volatility

MoonLake Immunotherapeutics (NASDAQ: MLTX), a Swiss-based biotechnology firm, has been making waves in the healthcare sector with its innovative approach to tackling inflammatory skin and joint diseases. With the development..

BioCryst Pharmaceuticals, Inc. (BCRX) Stock Analysis: Potential Upside of 164.94% Catches Investor Attention

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) has been garnering attention from the investment community, with a formidable potential upside of 164.94% based on current analyst ratings. This biotechnology firm, specializing in..

Ultragenyx Pharmaceutical Inc. (RARE): Analyst Ratings Reveal 124.55% Potential Upside in Rare Disease Market

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a prominent player in the biotechnology sector, is drawing significant attention from investors due to its focus on the development and commercialization of treatments for..

Immunovant, Inc. (IMVT) Investor Outlook: Unpacking a Potential 67.46% Upside

Immunovant, Inc. (NASDAQ: IMVT), a clinical-stage biotech company specializing in immunology, is attracting significant investor attention with a potential upside of 67.46%. Based in New York and operating as a..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Exploring a 25.81% Upside Potential Amidst Solid Revenue Growth

LeMaitre Vascular, Inc. (NASDAQ: LMAT), a key player in the healthcare sector specializing in medical instruments and supplies, presents a compelling case for investors with its intriguing blend of solid..

Search

Funds

December 9, 2025

Search

Funds

December 9, 2025

FTSE 100

Funds